Shehla Admani, MD
Clinical Associate Professor, Dermatology
Bio
Shehla Admani is a Clinical Assistant Professor of Dermatology at Stanford University, School of Medicine. Dr. Admani completed her dermatology residency at the University California, San Diego where she served as chief resident during her final year. She then completed her pediatric dermatology fellowship at Stanford University, School of Medicine and has stayed on as faculty since that time. She is board certified in dermatology and pediatric dermatology. Dr. Admani’s academic interests include pediatric dermatology, vulvar dermatology and teledermatology.
Clinical Focus
- Pediatric Dermatology
Professional Education
-
Medical Education: University of California at Irvine School of Medicine (2011) CA
-
Board Certification: American Board of Dermatology, Pediatric Dermatology (2018)
-
Fellowship: Stanford University Pediatric Dermatology (2018) CA
-
Board Certification: American Board of Dermatology, Dermatology (2017)
-
Residency: UCSD Dermatology Residency (2017) CA
-
Internship: University of California Irvine Dept of Internal Medicine (2012) CA
All Publications
-
Draining Lesions in the Intergluteal Cleft
JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION
2023; 15 (6): 292-293
View details for DOI 10.1097/JDN.0000000000000765
View details for Web of Science ID 001110312400001
-
Vulvar allergens in topical preparations recommended on social media: a cross-sectional analysis of Facebook groups for lichen sclerosus.
International journal of women's dermatology
2023; 9 (3): e097
View details for DOI 10.1097/JW9.0000000000000097
View details for PubMedID 37469804
-
Evaluation of a Yellowish-Tan Plaque Surrounding a Preexisting Nevus (Book Review)
JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION
2023; 15 (5): 240-241
View details for DOI 10.1097/JDN.0000000000000757
View details for Web of Science ID 001180538700003
-
Nevus Simplex A Review
JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION
2023; 15 (2): 84-85
View details for DOI 10.1097/JDN.0000000000000730
View details for Web of Science ID 000971952200006
-
Halo Nevi in the Pediatric Population
JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION
2023; 15 (1): 41-45
View details for DOI 10.1097/JDN.0000000000000719
View details for Web of Science ID 000916888600005
-
Dermal Melanocytosis
JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION
2022; 14 (4): 161-162
View details for DOI 10.1097/JDN.0000000000000694
View details for Web of Science ID 000827794200005
-
Localized systemic contact dermatitis: The vulva as a clue to identify allergen ingestion.
International journal of women's dermatology
1800; 7 (5Part B): 843-844
View details for DOI 10.1016/j.ijwd.2021.02.009
View details for PubMedID 35028397
-
Scabies Infestation in the Pediatric Population
JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION
2021; 13 (6): 301-304
View details for DOI 10.1097/JDN.0000000000000653
View details for Web of Science ID 000718488700003
-
Lice Infestations in the Pediatric Population
JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION
2021; 13 (5): 284-287
View details for DOI 10.1097/JDN.0000000000000636
View details for Web of Science ID 000698718500009
-
COVID-19 Pandemic Leading to the Accelerated Development of a Virtual Health Model for Isotretinoin
JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION
2021; 13 (1): 54–57
View details for DOI 10.1097/JDN.0000000000000595
View details for Web of Science ID 000621110800009
-
COVID-19 Pandemic Leading to the Accelerated Development of a Virtual Health Model for Isotretinoin.
Journal of the Dermatology Nurses' Association
2020; 13 (1): 54-57
Abstract
Isotretinoin is a highly efficacious medication for the treatment of acne vulgaris; however, its prescription is subject to the strict requirements of the iPLEDGE restricted distribution program. These requirements have placed significant financial, time, and logistical burdens on patients taking the medication. The stay-at-home ordinances enacted by many states during the 2019 novel coronavirus (COVID-19) global pandemic have accelerated previous trends toward utilization of telehealth and decreased laboratory monitoring in the care of patients on isotretinoin. Recent changes to the iPLEDGE program allowing use of at-home pregnancy tests to meet monthly pregnancy test requirements during the pandemic have increased availability of testing options for patients of child-bearing potential on isotretinoin. The change to use of at-home pregnancy test monitoring as well as long-term trends toward increasing access to isotretinoin through the use of telehealth are discussed.
View details for DOI 10.1097/JDN.0000000000000595
View details for PubMedID 34191969
View details for PubMedCentralID PMC7813218
-
Aquagenic pruritus in an adolescent effectively managed with beta-alanine supplementation.
Pediatric dermatology
2020
Abstract
Aquagenic pruritus is a rare debilitating condition, which can be idiopathic, iatrogenic, or associated with systemic disease. In idiopathic cases, treatment can be challenging as options are limited and of variable efficacy. Here, we report the case of a teenage boy with refractory idiopathic aquagenic pruritus effectively managed with administration of beta-alanine supplementation, a treatment gaining traction in lay media but not yet reported in the medical literature. This report adds to the limited options published for treatment of idiopathic aquagenic pruritus in pediatric patients.
View details for DOI 10.1111/pde.14440
View details for PubMedID 33170524
-
Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child.
JAMA dermatology
2018
View details for PubMedID 30566190
-
Wash-Line Dermatitis: A Diagnostic Clue.
The Journal of clinical and aesthetic dermatology
2018; 11 (10): 12
View details for PubMedID 30519373
-
DYE ALLERGY ASSOCIATED WITH CONTACT WITH HELLO KITTY LUNCH BOX.
The Journal of clinical and aesthetic dermatology
2018; 11 (9): 12
View details for PubMedID 30319725
-
Response Letter to "Contact Dermatitis Associated with Alopecia and Hyperpigmentation".
Pediatric dermatology
2017; 34 (5): 626
View details for DOI 10.1111/pde.13249
View details for PubMedID 28884898